Low Glycemic Load Diet in Patients With Stage I-III Colon Cancer

Completed · Not applicable

Conditions studied: Stage I Colon Cancer, Stage II Colon Cancer, Stage III Colon Cancer, Stage I Rectal Cancer, Stage II Rectal Cancer, Stage III Rectal Cancer

In brief

This pilot clinical trial studies the feasibility of a low glycemic load diet in patients with stage I-III colon cancer. A low glycemic load diet includes foods that have low scores on the glycemic index. The glycemic index is a scale that measures how much a certain carbohydrate causes a person's blood sugar to rise. A low glycemic load diet may help decrease the chance of cancer coming back and improve the survival in patients with colon cancer.

Key facts

Study ID

NCT02129218

Run by

Case Comprehensive Cancer Center

People needed

18

Starts

2015-02-16

Expected to finish

2018-07-10

Last updated by the study team

2018-07-20

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients must have stage I-III colon or rectal cancer and have undergone definitive therapy; definitive therapy may have included surgery alone, or surgery plus neoadjuvant and/or adjuvant therapy
• Patients must regularly consume a diet with a glycemic load > 150 as estimated through the 3 day food recall
• Patients must readily be available for a 3 month period and agree to participate in regular dietary adherence assessments (surveys and phone interviews)

You may not qualify if…

• Current participation in an intervention targeting diet or exercise

Where it is running

• Case Comprehensive Cancer Center — Cleveland, Ohio, United States
• Metrohealth Medical Center — Cleveland, Ohio, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.